Literature DB >> 17553403

[Severe pelvic fractures, associated injuries and hemodynamic instability: incidence, management and outcome in our center].

Juan María Sánchez-Tocino1, Fernando Turégano-Fuentes, Dolores Pérez-Díaz, Mercedes Sanz-Sánchez, Jesús Lago-Oliver, Jaime Zorrilla-Ortúzar, Darío Martínez-Baena.   

Abstract

INTRODUCTION: The aim of this study was to review the incidence, treatment and outcome of severe pelvic fractures, as well as associated injuries, in our center. PATIENTS AND
METHOD: We performed a retrospective study of patients included in our trauma registry between June 1993 and January 2005. Pelvic fractures were classified according to the system proposed by Tile. Clinical and demographic data such as age, gender, mechanism of injury, transfer time, hemodynamic status, and trauma scores were compared and analyzed statistically. Shock was defined as a systolic blood pressure of < or = 90 mmHg during the primary assessment. Mortality and associated risk factors were analyzed, with emphasis on patients in shock on admission.
RESULTS: Of 1274 patients with severe trauma admitted during the study period, 192 (15%) had pelvic fracture. Only 6.7% were isolated fractures and 6% were open fractures. Twenty percent of the patients were in shock on admission. The mean Injury Severity Score of the series was 28.5 +/- 14 and that of patients in shock was 38 +/- 16. The most frequently associated injuries were thoracic (70%), abdominal (55%), long bone fractures (52%), and head injuries (40%). Twenty-three percent of the patients had retroperitoneal hematoma. Arteriograms were performed in 16 patients, with four embolizations. Eight patients underwent external orthopedic fixation, and none posterior orthopedic fixation. Five patients underwent pelvic packing and two patients underwent ligation of hypogastric arteries. Overall mortality was 30% and mortality in patients in shock was 61%. Predictors of mortality were shock on admission, a Glasgow Coma Scale score of < or = 8, ISS > 25 and age > 55 years.
CONCLUSIONS: Patients in shock with pelvic fractures have a poor prognosis in our center, frequently related to the severity of associated injuries, the relative rarity of these fractures, and the lack of a clearly defined management protocol. The main cause of death was massive hemorrhage.

Entities:  

Mesh:

Year:  2007        PMID: 17553403     DOI: 10.1016/s0009-739x(07)71330-1

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  6 in total

1.  Sepsis in fatal pelvic trauma patients: report from a level-1 Indian Trauma Centre.

Authors:  S Lalwani; N Rajkumari; P Mathur; V Sharma; V Trikha
Journal:  Eur J Trauma Emerg Surg       Date:  2015-02-20       Impact factor: 3.693

Review 2.  [Injury severity and pattern at the scene. What is the influence of the mechanism of injury?].

Authors:  M Frink; C Zeckey; C Haasper; C Krettek; F Hildebrand
Journal:  Unfallchirurg       Date:  2010-05       Impact factor: 1.000

Review 3.  Angiographic embolisation of pelvic ring injuries. Treatment algorithm and review of the literature.

Authors:  Efthimios J Karadimas; Tony Nicolson; Despoina D Kakagia; Stuart J Matthews; Paula J Richards; Peter V Giannoudis
Journal:  Int Orthop       Date:  2011-05-17       Impact factor: 3.075

Review 4.  Challenges of surgical trauma emergency admission.

Authors:  Michael Frink; Philipp Mommsen; Hagen Andruszkow; Christian Zeckey; Christian Krettek; Frank Hildebrand
Journal:  Langenbecks Arch Surg       Date:  2011-03-08       Impact factor: 3.445

5.  Management of Open Tile C Pelvic Fractures and Their Outcomes: A Retrospective Study of 30 Cases.

Authors:  Shun Lu; Fanxiao Liu; Weicheng Xu; Xiaofeng Zhou; Lianxin Li; Dongsheng Zhou; Qinghu Li; Jinlei Dong
Journal:  Ther Clin Risk Manag       Date:  2022-09-10       Impact factor: 2.755

6.  Treatment outcomes of open pelvic fractures associated with extensive perineal injuries.

Authors:  Ebrahim Ghayem Hasankhani; Farzad Omidi-Kashani
Journal:  Clin Orthop Surg       Date:  2013-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.